Skip to main content

ADVERTISEMENT

Stenting

Interview
01/26/2016
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a...
01/26/2016
Vascular Disease Management
Original Research
12/30/2015
Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.
Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.
Stent fractures in the SFA play...
12/30/2015
Vascular Disease Management
Clinical Editor's Corner
12/30/2015
Despite new technologies and research, stent fracture continues to be a challenge faced by vascular specialists. 
Despite new technologies and research, stent fracture continues to be a challenge faced by vascular specialists. 
Despite new technologies and...
12/30/2015
Vascular Disease Management
Review
10/03/2015
This review describes the use of covered stents in endovascular treatment of chronic mesenteric ischemia, including indications, techniques, and results.
This review describes the use of covered stents in endovascular treatment of chronic mesenteric ischemia, including indications, techniques, and results.
This review describes the use of...
10/03/2015
Vascular Disease Management
Review
08/29/2015

Osamu Iida, MD

 

Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan

Osamu Iida, MD   Kansai Rosai Hospi...
Although endovascular therapy of femoropopliteal lesions with nitinol bare metal stents improves the relatively low primary patency rates achieved with balloon angioplasty, up to 37% of BMS-treated femoropopliteal lesions develop in-stent...
Although endovascular therapy of femoropopliteal lesions with nitinol bare metal stents improves the relatively low primary patency rates achieved with balloon angioplasty, up to 37% of BMS-treated femoropopliteal lesions develop in-stent...
Although endovascular therapy of...
08/29/2015
Vascular Disease Management
Case Report
03/27/2015
The authors report the case of a 56-year-old male who had embolism of a fully deployed stent from the right coronary ostium to his brachial artery during percutaneous coronary intervention.
The authors report the case of a 56-year-old male who had embolism of a fully deployed stent from the right coronary ostium to his brachial artery during percutaneous coronary intervention.
The authors report the case of a...
03/27/2015
Vascular Disease Management
Original Contribution
01/09/2015
We analyzed data from the ongoing multicenter XLPAD registry to report on the use of non-stent (atherectomy ± balloon angioplasty) and stent-based treatment of superficial femoral ar-tery (SFA), popliteal, and below-the-knee (BTK) vessels in...
We analyzed data from the ongoing multicenter XLPAD registry to report on the use of non-stent (atherectomy ± balloon angioplasty) and stent-based treatment of superficial femoral ar-tery (SFA), popliteal, and below-the-knee (BTK) vessels in...
We analyzed data from the...
01/09/2015
Journal of Invasive Cardiology
Original Contribution
01/09/2015
Takayasu’s arteritis (TA) is a rare inflammatory, granulomatous vasculitis primarily involving the aorta and its major branches. This study analyzes and describes the clinical features, angiographic profile, and endovascular interventions in...
Takayasu’s arteritis (TA) is a rare inflammatory, granulomatous vasculitis primarily involving the aorta and its major branches. This study analyzes and describes the clinical features, angiographic profile, and endovascular interventions in...
Takayasu’s arteritis (TA) is a...
01/09/2015
Journal of Invasive Cardiology
Clinical Editor's Corner
11/05/2014
Given what we now understand about closure devices and femoral angiography, I found it strange that this question would come up, but I put it out to my colleagues on the “Cath List” to see what the conversation might be. 
Given what we now understand about closure devices and femoral angiography, I found it strange that this question would come up, but I put it out to my colleagues on the “Cath List” to see what the conversation might be. 
Given what we now understand...
11/05/2014
Cath Lab Digest
10/27/2014
Cardiac allograft vasculopathy (CAV) is an immunologically-mediated phenomenon that occurs in up to 50% of patients surviving to 10 years post orthotopic heart transplant. While the pediatric subgroup of OHT recipients has a lower overall...
Cardiac allograft vasculopathy (CAV) is an immunologically-mediated phenomenon that occurs in up to 50% of patients surviving to 10 years post orthotopic heart transplant. While the pediatric subgroup of OHT recipients has a lower overall...
Cardiac allograft vasculopathy...
10/27/2014
Journal of Invasive Cardiology